PEP-THERAPY

PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology... PEP-Therapy, which was founded in 2014 and builds on research from Sorbonne University and Institut Curie, is backed by international investors: Seventure Partners, Italian Angels for Growth, Doorway, Magna Capital Partners, CapHorn, i&i Prague, Business Angels des Grandes Ecoles (BAdGE), and Jérôme Majoie (former Managing Director of Laboratoires Fournier affiliates (USA, UK, Sweden, Japan), CEO of La Fondation Fournier-Majoie).

Primary location: Evry France